Sarcomas Recruiting Phase 1 Trials for Nivolumab (DB09035)

Also known as: Sarcoma / Malignant neoplasm of soft tissues / Malignant soft tissue neoplasm / Malignant soft tissue neoplasm NOS / Soft tissue cancer / Sarcoma NOS / Soft tissue sarcoma

IndicationStatusPhase
DBCOND0041813 (Sarcomas)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03829436TPST-1120 as Monotherapy and in Combination With (Nivolumab, Docetaxel or Cetuximab) in Subjects With Advanced CancersTreatment